Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260
  • Resources
  • Innopedia Database
  • Products

    Engineered Cell Lines

    • Kinase Cell Line
    • Immune Molecule Cell Line
    • Gene Editing Cell Line
    • Reporter Cell Line
    • Fluorescence Labeled Cell Line
    • Drug Resistant Cell Line
    • Tumor Antigen Cell Line

    Customized Cell Line Construction

    Cancer Cell Lines

    • Human Cell Line
    • Animal Cell Line

    Antibodies

    • Hybridoma
    • Isotype Control
    • Recombinant Protein
    • Reference Antibody
    • Customized Antibody Production
  • Technology
    • Genetically Engineered Cell Lines
    • In Vitro and In Vivo Pharmacology
    • Multispecific Antibody Development Platform
    • MPSA-AB5000 Panel
    • AI-Based Antibody Development Platform
  • Services

    In Vitro Services

    • Cell Proliferation Assay
    • MegaScreen
    • Organoids
    • Internalization Assay
    • ELISA Assay
    • FACS Binding Assay
    • Immuno-Oncology Assay
    • ADCC/ADCP Assay

    In Vivo Services

    • Ba/F3 Xenograft Model
    • Gene-editing Xenograft Model
    • Luciferase Tumor Model
    • PBMC Humanized Mouse Model
    • Syngeneic Model
    • Orthotopic Model
    • Subcutaneous Model
    • Metastasis Model

    Antibody Discovery Services

    • Common Light Chain Platform
    • Nanobody Platform
    • AI Based-Antibody Engineering
    • Antibody off-target screening

    Drug Combination Services

    • In Vitro Combination
    • In Vivo Combination
  • About Us
  • News
Contact
  • Resources
  • Innopedia Database
[gtranslate]
  • Products

    Engineered Cell Lines

    • Kinase Cell Line
    • Immune Molecule Cell Line
    • Gene Editing Cell Line
    • Reporter Cell Line
    • Fluorescence Labeled Cell Line
    • Drug Resistant Cell Line
    • Tumor Antigen Cell Line

    Customized Cell Line Construction

    Cancer Cell Lines

    • Human Cell Line
    • Animal Cell Line

    Antibodies

    • Hybridoma
    • Isotype Control
    • Recombinant Protein
    • Reference Antibody
    • Customized Antibody Production
  • Technology
    • Genetically Engineered Cell Lines
    • In Vitro and In Vivo Pharmacology
    • Multispecific Antibody Development Platform
    • MPSA-AB5000 Panel
    • AI-Based Antibody Development Platform
  • Services

    In Vitro Services

    • Cell Proliferation Assay
    • MegaScreen
    • Organoids
    • Internalization Assay
    • ELISA Assay
    • FACS Binding Assay
    • Immuno-Oncology Assay
    • ADCC/ADCP Assay

    In Vivo Services

    • Ba/F3 Xenograft Model
    • Gene-editing Xenograft Model
    • Luciferase Tumor Model
    • PBMC Humanized Mouse Model
    • Syngeneic Model
    • Orthotopic Model
    • Subcutaneous Model
    • Metastasis Model

    Antibody Discovery Services

    • Common Light Chain Platform
    • Nanobody Platform
    • AI Based-Antibody Engineering
    • Antibody off-target screening

    Drug Combination Services

    • In Vitro Combination
    • In Vivo Combination
  • About Us
  • News
Contact
  • CRISPR-edited cell lines targeting key molecular pathways
  • A novel approach for antibody affinity maturation using AI-driven mutation prediction
  • MPSA-AB5000: A high-throughput membrane protein screening array for therapeutic biologics specificity profiling
  • Over 200! The largest BaF3-EGFR engineered cell line collection A versatile platform for novel drug discovery
  • FGFR cell lines: A comprehensive approach to drug discovery and evaluation, from small molecules to biologics
  • Improved Ba/F3 kinase engineered cell lines :An innovative in vivo screening platform
  • LgBiT-HiBiT engineered cell lines for protein degradation detection:Comprehensive PROTAC evaluation platform with endpoint and real-time kinetic analysis
  • MegaScreen,A robust platform for ADC drug evaluation
  • In vitro and in vivo screening platform for discovery of JAK2 inhibitor
  • KA-3123-LD38:A novel bispecific ADC targeting EGFR and B7H3 with a DNA topoisomerase I inhibitor payload
  • KA-2887-LD38:A bispecific ADC targeting both EGFR and PD-L1
  • KA-2886-LD38:A bispecific ADC targeting both EGFR and MET, incorporating a novel linker-payload that inhibits DNA topoisomerase I
Please enable JavaScript in your browser to complete this form.
Name *
Loading

China

F2 Building, Yizhuang Biomedical Park, No. 88, Kechuang Six Street, Beijing. P.R. China. 101111.

USA

  • 3 Gill Street, suite 100, Woburn,
    MA, 01801
  • +1 (617) 937-9703
  • +1 (617) 937-9720

Contact Us

  • bd@kyinno.com
  • (China): +86 (10)58222701
  • (USA): +1 (617) 937-9720

© 2025 Kyinno Biotechnology | Site Credits |  Privacy Policy | Accessibility Policy | Sitemap

Linkedin

Fillup the form to download the PDF!